Share 'Webinar: Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne'
Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne: Results of the phase 3 double-blind, randomized, placebo-controlled DELOS trial
Santhera Pharmaceuticals presented data of the Phase III DELOS trial during a webinar hosted by Parent Project Muscular Dystrophy on Wednesday, October 15th at 12pm eastern.
Prof. Gunnar Buyse (University Hospitals Leuven, Belg…
You can share this event in two ways…
Share this link:
Send it with your computer's email program: Email this